AstraZeneca gets DCGI nod for asthma drug ...Middle East

Devdiscourse - Opinion
AstraZeneca gets DCGI nod for asthma drug
Drug firm AstraZeneca India on Tuesday said it has received marketing authorisation for an asthma drug from the Drugs Controller General of India (DCGI). The company has received approval from the DCGI for Fasenra (Benralizumab solution for injection in a single dose prefilled syringe30 mg/ml) for patients with severe asthma (eosinophilic asthma), AstraZeneca India said in a statement.

Hence then, the article about astrazeneca gets dcgi nod for asthma drug was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca gets DCGI nod for asthma drug )

Apple Storegoogle play

Last updated :

Also on site :



Latest News